Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This Traditional Chinese Medicine (TCM) formulation is a complex herbal mixture developed by Peking Union Medical College Hospital for the adjunctive treatment of severe pneumonia and respiratory failure. Evaluated in the CARP-RF (Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure) trial, the formulation comprises twelve herbal components: Trichosanthes and Rhubarb (Monarch herbs); Gypsum, Bitter Apricot Seed, Descurainia Seed, and Verbena (Minister herbs); Glehnia, Adenophora, Astragalus, Ophiopogon, and Schisandra (Assistant herbs); and Licorice (Guide herb). It is administered twice daily via oral or enteral routes for seven days to ICU patients requiring invasive mechanical ventilation. The treatment aims to reduce 28-day all-cause mortality by leveraging the synergistic effects of its botanical constituents, though specific molecular targets are not defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Traditional Chinese Medicine formulation (CARP-RF).